FDA Reverses Course, Allows Sarepta to Resume Duchenne Gene Therapy Shipments on July 29, 2025 Elevidys gene therapy Muscular Dystrophy, Duchenne Pauses Resumption Safety shipment United States Food and Drug Administration +
FDA Official Says Sarepta Faces Major Hurdles to Reintroduce DMD Therapy Elevidys on July 25, 2025 approval status CBER concerns Elevidys gene therapy Muscular Dystrophy, Duchenne Pauses Safety Scientific Study shipment United States Food and Drug Administration +
Roche Halts Elevidys Distribution in Several Countries Following Sarepta and FDA Safety Concerns on July 23, 2025 concerns Elevidys gene therapy halt Muscular Dystrophy, Duchenne patient deaths Roche (company) Safety shipment United States Food and Drug Administration +
Sarepta Halts US Shipments of Duchenne Therapy Elevidys After FDA Pressure on July 23, 2025 concerns DMD Elevidys gene therapy Muscular Dystrophy, Duchenne patient deaths Safety shipment Suspensions United States Food and Drug Administration +
Sarepta, bowing to FDA pressure, pauses shipments of Duchenne gene therapy Elevidys on July 22, 2025 Elevidys gene therapy Muscular Dystrophy, Duchenne patient deaths Pauses Safety shipment United States Food and Drug Administration +
Merck Suspends Gardasil Shipments to China, Lowers 2025 Revenue Forecast on February 05, 2025 Cancer Vaccines China Gardasil Merck shipment Suspensions +